PMID: 11926789Apr 3, 2002Paper

Acquired aplastic anemia

Annals of Internal Medicine
Neal S Young

Abstract

In aplastic anemia, hematopoiesis fails: Blood cell counts are extremely low, and the bone marrow appears empty. The pathophysiology of aplastic anemia is now believed to be immune-mediated, with active destruction of blood-forming cells by lymphocytes. The aberrant immune response may be triggered by environmental exposures, such as to chemicals and drugs or viral infections and, perhaps, endogenous antigens generated by genetically altered bone marrow cells. In patients with post-hepatitis aplastic anemia, antibodies to the known hepatitis viruses are absent; the unknown infectious agent may be more common in developing countries, where aplastic anemia occurs more frequently than it does in the West. The syndrome paroxysmal nocturnal hemoglobinuria (PNH) is intimately related to aplastic anemia because many patients with bone marrow failure have an increased population of abnormal cells. In PNH, an entire class of proteins is not displayed on the cell surface because of an acquired X-chromosome gene mutation. The PNH cells may have a selective advantage in resisting immune attack. In contrast, the disease myelodysplasia can be confused with aplasia and can also evolve from aplastic anemia. The occurrence of cytogenetic abnorm...Continue Reading

Citations

Jul 5, 2003·International Journal of Hematology·Akihiko TaguchiKenji Shinohara
Nov 15, 2002·International Journal of Hematology·Jaroslaw P MaciejewskiNeal S Young
Oct 22, 2010·European Journal of Clinical Pharmacology·Jimin HanTae-Bum Kim
Jul 14, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Ali AgoolRiemer H J A Slart
Feb 1, 2011·Annals of Hematology·José Carlos Jaime-PérezDavid Gómez-Almaguer
Jan 20, 2007·International Urology and Nephrology·Onur KirkizlarRumeyza Kazancioglu
Apr 25, 2009·Indian Journal of Pediatrics·Vijay K SharmaSophie Fletcher
Apr 23, 2013·International Journal of Hematology·Seung Hwan Shin, Jong Wook Lee
Jan 22, 2004·Archives of Medical Research·Jaroslaw P Maciejewski, Antonio Risitano
Dec 16, 2010·The British Journal of Nutrition·Ling HeLi Jia
Apr 9, 2005·The New England Journal of Medicine·Hiroki YamaguchiNeal S Young
Nov 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·David DingliJorge M Pacheco
Aug 2, 2012·Anti-cancer Drugs·Sanjay DixitMohan Hingorani
Jan 27, 2012·Journal of Pediatric Hematology/oncology·Rajni SharmaVarinder Singh
Aug 12, 2009·Southern Medical Journal·Benjamin J GeorgeThomas J Richard
Jan 11, 2005·British Journal of Haematology·Naoto HiranoSeiji Kojima
Sep 1, 2012·Case Reports in Hematology·Radha Raghupathy, Olga Derman
May 18, 2011·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Songul SerefhanogluOsman I Ozcebe
Jan 18, 2011·Hematology·Mary Eapen, Mary M Horowitz
Apr 18, 2009·Blood·Robert A Brodsky
Mar 1, 2011·Virology Journal·Bisma RauffMuhammad Ali
Feb 18, 2011·Journal of Medical Case Reports·Krista Jm StibbePieternella J Lugtenburg
Jul 16, 2010·Journal of Hematology & Oncology·Marnelli A Bautista-QuachChung-Tsen Hsueh
Oct 7, 2005·International Journal of Hematology·Jichun Chen
Aug 7, 2007·International Journal of Hematology·Tatsuya Kawaguchi, Hideki Nakakuma
May 26, 2005·International Journal of Hematology·Can BogaIlhan Tuncer
Nov 19, 2010·Drug Metabolism and Pharmacokinetics·Xiaochu ZhangJack Uetrecht
Feb 21, 2014·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Rajeshwari Satish HandigundSuvarna Inumella
Jan 7, 2011·Case Reports in Medicine·Gazi ComezCelalettin Camci
Jul 14, 2005·Clinical Medicine & Research·Jichun Chen
Oct 29, 2005·Blood·Surapol IssaragrisilNeal S Young
Dec 28, 2007·Nucleic Acids Research·Jonathan Kenyon, Stanton L Gerson
Mar 12, 2013·Pharmacological Reviews·Jack Uetrecht, Dean J Naisbitt
Jul 3, 2013·The Medical Clinics of North America·Jenny Wright, Douglas S Paauw
Apr 3, 2012·Hematology/oncology Clinics of North America·Locke J Bryan, Neil A Zakai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.